Table 1.
Example for cancer-related HLA peptides identified from soluble HLA molecules of cancer patients
| Peptide | Access | Protein | Source | HLA haplotype score |
| YPFIIDAHL | Q9NXF1 | Testis-expressed sequence 10 protein | AML-1, healthy 1 | Cw04:106, B35:20 |
| GRWPWQGSL | Q9Y6M0 | Testisin | AML-1 | B27:10000 |
| SSVPRTAEL | Q99836 | Myeloid differentiation primary response protein MyD88 | MM-1 | |
| GRAPGGLSL | P17275 | Transcription factor jun-B | AML-1 | B27:2000 |
| IGVDFALKV | Q13637 | Ras-related protein Rab-32 | MM-1 | B51:240 |
| GTPAGGGFPR | Q07352 | Butyrate response factor 1 | MM-1, MM-2 | A11:2 |
| SVSNVVITK | P42566 | Epidermal growth factor receptor substrate 15 | MM-1, MM-2, AML-1, AML-3, ALL-1 | A03:18, A11:4 |
| VFDPVPVGV | Q08211 | ATP-dependent RNA helicase A | AML-1 | Cw04:45 |
| GQLSVHTPK | Q9H334 | Forkhead box protein P1 | AML-1 | B27:200 |
| DGYVVKETI | Q15418 | Ribosomal protein S6 kinase alpha-1 | ALL-1 | B51:532 |
Access, accession number in the UniProt database; HLA haplotype score, the best scores matching the HLA haplotype of the blood donors. The HLA types of the blood donors are listed in Table S1.